Analyst Ratings For Zymergen
Analysts have provided the following ratings for Zymergen (NASDAQ:ZY) within the last quarter:
JP Morgan Downgrades Zymergen to Underweight, Announces $12 Price Target
JP Morgan analyst Tycho Peterson downgrades Zymergen (NASDAQ:ZY) from Neutral to Underweight and announces $12 price target.
Where Zymergen Stands With Analysts
Analysts have provided the following ratings for Zymergen (NASDAQ:ZY) within the last quarter:
10 Biggest Price Target Changes For Tuesday
Morgan Stanley raised Lowe's Companies, Inc. (NYSE: LOW) price target from $230 to $240. Lowe's shares rose 0.5% to $206.00 in pre-market trading.
UBS Downgrades Zymergen to Neutral, Lowers Price Target to $13
UBS analyst John Sourbeer downgrades Zymergen (NASDAQ:ZY) from Buy to Neutral and lowers the price target from $56 to $13.
54 Biggest Movers From Yesterday
Gainers
Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares jumped 202.8% to settle at $46.33 on Wednesday after gaining over 11% on Tuesday. Regencell Bioscience recently reported partial exercise of underwriter’s over-allotment option.
Cathie Wood’s ARK Invest Posts Fund Purchases For Friday, Aug. 20, 2021: FATE, SRNG, BEAM, SGFY, TSP, VCYT, PLTR, AVAV, MKFG, BLDE, SPFR, FTCH, GENI, KVSB, LPSN, SMFR, MASS, RPTX, QSI, ZY, PATH
Fate Therapeutics (FATE) - 397,896
Soaring Eagle Acquisition Corp (SRNG) - 273,629
Beam Therapeutics (BEAM) - 40,061
Signify Health (SGFY) - 18,900
Tusimple Holdings (TSP) - 1,970
Veracyte (VCYT) -
Cathie Wood’s ARK Invest Posts Fund Purchases For Thursday, Aug. 19, 2021: PLTR, ZY, SURF, SRNG, SMFR, RPTX, DYNS, QSI, MASS, VCYT, TSP, SGFY, NTLA, EDIT, CRSP, BEAM, SPFR, MKFG, KMTUY, AVAV, GENI, KVSB, LPSN
Palantir Technologies (PLTR) - 368,311 Shares
Zymergen (ZY) - 109,777
Surface Oncology (SURF) - 86,170
Soaring Eagle Acquistion (SRNG) - 435,860
Sema4 (SMFR) - 176,046
Repare Therapeutics (RPTX) - 18,596
Dynamics